Hints and tips:
...estimates that developed economies will contract by 6.1 per cent this year, much more than the 1.1 per cent rate predicted for emerging markets, and Mr Dehn said that “for most of EM it will be a relatively V-shaped...
...A spokesperson for Merck Sharp & Dohme – the name under which the US group operates in Europe – said it is cooperating fully with the CMA’s investigation, and said: MSD is confident that the proceedings...
...Johnson & Johnson (Biotech & Pharma) 8. Walt Disney (Media) 9. Prudential Financial (Finance) 10. Audi (Automotive) 11. Cisco Systems (Communication) 12. British American Tobacco (Tobacco) 13....
...But the problem for N Brown is that such a sharp drop in expected profit seems a lot to attribute to some sunny days....
...Andrew Edgecliffe-Johnson is the FT’s media editor ………………………………………….....
...Withdrawing the rights outside the US and Asia from Schering-Plough of Remicade would mark a sharp blow to Merck’s acquisition by reducing annual sales by more than $2bn and sacrificing sales forecast after...
...Jo Johnson is the FT’s bureau chief in Delhi....
...Merck weighed on the blue-chip index....
...The news sent shares in fellow drugmaker Merck 7.5 per cent higher to $32.25 while Johnson & Johnson gained 2.1 per cent to $61.19....
International Edition